We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Agilent Technologies and BioTrove Sign Collaborative Marketing Agreement for Ultra-High-Throughput Mass Spectrometry Solution

News   Oct 17, 2007

 
Agilent Technologies and BioTrove Sign Collaborative Marketing Agreement for Ultra-High-Throughput Mass Spectrometry Solution
 
 
 

RELATED ARTICLES

Fighting the Good Fight

News

Blocking an important enzyme in staphylococcal metabolism in a targeted manner would allow the pathogens to be starved.

READ MORE

HPV-Positive Throat Cancer Patients Should Keep Taking Chemotherapy

News

Patients with human papillomavirus (HPV)-positive throat cancer should carry on receiving chemotherapy rather than switching to a targeted cancer drug during curative radiotherapy, new clinical trial results have shown.

READ MORE

Membrane Proteins Ejected Directly from Cell Membrane to Mass Spec

News

A new approach to analyzing cell membrane proteins in situ could revolutionize the way in which we study diseases, such as cancer, metabolic and heart diseases.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE